bearish
CStone Pharma (基石药业) Post-IPO: Strong Debut but Lacks near Term Catalysts
596 Views26 Feb 2019 15:21
CStone Pharma's IPO was priced at HKD 12.00/share and started trading today. In this insight, we summarize the allocation, the use of proceeds and...
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 4-minute read)
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- CStone Pharma's (基石药业) Lock-Up Expiry - A Review of Valuation19 Aug 2019
- CStone Pharma's (基石药业) Lock-Up Expiry - Analysis of Potential Selling Shareholders15 Aug 2019
- CStone Pharma's (基石药业) Lock-Up Expiry - Lack of Material Newsflow for Core Drug Candidates14 Aug 2019
- CStone Pharma (基石药业) IPO: Thoughts on Valuation (Part 2)11 Feb 2019
- CStone Pharma (基石药业) IPO: Strong Assembly and Backing (Part 1)25 Jan 2019
x